Table 1.
Characteristics of participants enrolled in the Evaluating Medication for Addictions Treatment (E-MAT) Study.
| Characteristics | n | % |
|---|---|---|
|
| ||
| MAT Type | ||
| Methadone | 20 | 51% |
| Suboxone | 18 | 46% |
| Naltrexone | 1 | 3% |
| Continued a prescription from outside the RIDOC v. Initatiated while incarcerated | ||
| Continued | 20 | 51% |
| Initiated | 19 | 49% |
| Gender | ||
| Male | 27 | 69% |
| Female | 12 | 31% |
| Race | ||
| Black | 2 | 5% |
| White | 32 | 82% |
| Mixed/bi-racial | 1 | 3% |
| Other | 4 | 10% |
| Ethnicity | ||
| Hispanic | 4 | 10% |
| Non-hispanic | 35 | 90% |
| Sexual orientation | ||
| Straight | 34 | 87% |
| Gay | 2 | 5% |
| Bisexual | 3 | 8% |
| Highest education completed | ||
| Did not complete high school | 10 | 26% |
| Completed high school | 29 | 74% |